Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet

Published on Jul 15, 2013in American Journal of Physiology-endocrinology and Metabolism4.125
· DOI :10.1152/ajpendo.00442.2012
Masateru Ushio1
Estimated H-index: 1
(Shiga University of Medical Science),
Yoshihiko Nishio37
Estimated H-index: 37
(Kadai: Kagoshima University)
+ 8 AuthorsHiroshi Maegawa48
Estimated H-index: 48
(Shiga University of Medical Science)
Nonalcoholic fatty liver disease is the most frequent liver disease. Ezetimibe, an inhibitor of intestinal cholesterol absorption, has been reported to ameliorate hepatic steatosis in human and animal models. To explore how ezetimibe reduces hepatic steatosis, we investigated the effects of ezetimibe on the expression of lipogenic enzymes and intestinal lipid metabolism in mice fed a high-fat or a high-fructose diet. CBA/JN mice were fed a high-fat diet or a high-fructose diet for 8 wk with or without ezetimibe. High-fat diet induced hepatic steatosis accompanied by hyperinsulinemia. Treatment with ezetimibe reduced hepatic steatosis, insulin levels, and glucose production from pyruvate in mice fed the high-fat diet, suggesting a reduction of insulin resistance in the liver. In the intestinal analysis, ezetimibe reduced the expression of fatty acid transfer protein-4 and apoB-48 in mice fed the high-fat diet. However, treatment with ezetimibe did not prevent hepatic steatosis, hyperinsulinemia, and intestinal apoB-48 expression in mice fed the high-fructose diet. Ezetimibe decreased liver X receptor-α binding to the sterol regulatory element-binding protein-1c promoter but not expression of carbohydrate response element-binding protein and fatty acid synthase in mice fed the high-fructose diet, suggesting that ezetimibe did not reduce hepatic lipogenesis induced by the high-fructose diet. Elevation of hepatic and intestinal lipogenesis in mice fed a high-fructose diet may partly explain the differences in the effect of ezetimibe.
  • References (46)
  • Citations (24)
📖 Papers frequently viewed together
8 Citations
135 Citations
41 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
Nonalcoholic fatty liver disease (NAFLD) affects about 30% of the general population in the United States and includes a spectrum of disease that includes simple steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. Significant insight has been gained into our understanding of the pathogenesis of NALFD; however the key metabolic aberrations underlying lipid accumulation in hepatocytes and the progression of NAFLD remain to be elucidated. Accumulating and emerging evidence indi...
89 CitationsSource
#1Christopher D. Byrne (University of Southampton)H-Index: 54
Diabet. Med. 29, 1098–1107 (2012) Abstract Non-alcoholic fatty liver disease is now recognized as the hepatic component of the metabolic syndrome. Non-alcoholic fatty liver disease is a spectrum of fat-associated liver conditions that can result in end-stage liver disease and the need for liver transplantation. Simple steatosis, or fatty liver, occurs early in non-alcoholic fatty liver disease and may progress to non-alcoholic steatohepatitis, fibrosis and cirrhosis with increased risk of hepato...
52 CitationsSource
#1Mark Naples (U of T: University of Toronto)H-Index: 23
#2Chris Baker (U of T: University of Toronto)H-Index: 12
Last. Khosrow Adeli (U of T: University of Toronto)H-Index: 55
view all 6 authors...
Ezetimibe is a cholesterol uptake inhibitor that targets the Niemann-Pick C1-like 1 cholesterol transporter. Ezetimibe treatment has been shown to cause significant decreases in plasma cholesterol levels in patients with hypercholesterolemia and familial hypercholesterolemia. A recent study in humans has shown that ezetimibe can decrease the release of atherogenic postprandial intestinal lipoproteins. In the present study, we evaluated the mechanisms by which ezetimibe treatment can lower postpr...
33 CitationsSource
#1Tomonori Muraoka (YCU: Yokohama City University)H-Index: 4
#2Kazutaka Aoki (YCU: Yokohama City University)H-Index: 15
Last. Yasuo Terauchi (YCU: Yokohama City University)H-Index: 58
view all 11 authors...
Ezetimibe inhibits intestinal cholesterol absorption, thereby reducing serum cholesterol. Recent studies suggest that ezetimibe affects liver steatosis and insulin resistance. We investigated the impact of ezetimibe on insulin sensitivity and glucose metabolism in C57BL/6 mice. We analyzed 4 mouse groups fed the following diets: normal chow (4% fat) for 12 weeks, normal chow for 10 weeks followed by normal chow plus ezetimibe for 2 weeks, high-fat chow (32% fat) for 12 weeks, and high-fat chow f...
41 CitationsSource
#1Jose C. Sandoval (Osaka University)H-Index: 11
#2Yumiko Nakagawa-Toyama (Osaka University)H-Index: 16
Last. Shizuya Yamashita (Osaka University)H-Index: 59
view all 16 authors...
Aim: Postprandial hypertriglyceridemia (PHTG) has been shown repeatedly to be associated with metabolic syndrome and atherosclerotic cardiovascular diseases. We have recently reported that ezetimibe inhibits PHTG in patients with type IIb hyperlipidemia. Ezetimibe was also reported to atten-uate PHTG in combination with low-dose statins in patients with obesity or metabolic syndrome. We reported CD36-deficient (CD36KO) mice as a new model for PHTG, in which the synthesis of chylomicron (CM) in t...
33 CitationsSource
#1Jung Sub LimH-Index: 1
#2Michele Mietus-Snyder (UCSF: University of California, San Francisco)H-Index: 22
Last. Robert H. Lustig (UCSF: University of California, San Francisco)H-Index: 57
view all 5 authors...
Nonalcoholic fatty liver disease (NAFLD) is the most frequent liver disease worldwide, and is commonly associated with the metabolic syndrome. Secular trends in the prevalence of these diseases may be associated with the increased fructose consumption observed in the Western diet. NAFLD is characterized by two steps of liver injury: intrahepatic lipid accumulation (hepatic steatosis), and inflammatory progression to nonalcoholic steatohepatitis (NASH) (the 'two-hit' theory). In the first 'hit', ...
371 CitationsSource
#1Munechika Enjoji (Fukuoka University)H-Index: 34
#2Kazuyuki Machida (Fukuoka University)H-Index: 7
Last. MakotoNakamutaH-Index: 40
view all 8 authors...
Background We recently examined the distribution of abdominal fat, dietary intake and biochemical data in patients with nonalcoholic fatty liver disease (NAFLD) and found that non-obese NAFLD patients did not necessarily exhibit insulin resistance and/or dysregulated secretion of adipocytokines. However, dietary cholesterol intake was superabundant in non-obese patients compared with obese patients, although total energy and carbohydrate intake was not excessive. Therefore, excess cholesterol in...
58 CitationsSource
#1Roger H UngerH-Index: 114
#2Gregory O. ClarkH-Index: 4
Last. Lelio Orci (University of Geneva)H-Index: 121
view all 4 authors...
Abstract In the 20th century industrialized nations have become afflicted with an unprecedented pandemic of increased adiposity. In the United States, the epicenter of the epidemic, over 2/3 of the population, is overweight and 1 of every 6 Americans carries the diagnosis of metabolic syndrome. Although genes determine susceptibility to environmental factors, the epidemic is clearly due to increased consumption of calorie-dense, highly lipogenic foods, coupled with a marked decrease in physical ...
348 CitationsSource
The present study attempted to define the role of hepatic Niemann-Pick C1-like 1 (NPC1L1), a cholesterol transporter, in hepatic insulin resistance as well as hepatic steatosis. The inhibition of NPC1L1 and its molecular consequences were examined in Zucker obese fatty (ZOF) rats and cultured steatotic hepatocytes using ezetimibe, a pharmacoloigcal inhibitor of NPC1L1, and short hairpin RNA (shRNA) of NPC1L1. Ezetimibe improved hepatic insulin signaling as well as hepatic steatosis in ZOF rats. ...
60 CitationsSource
#1Kate S. CollisonH-Index: 17
#2Soad M. SalehH-Index: 9
Last. Futwan Al-MohannaH-Index: 27
view all 10 authors...
Nonalcoholic fatty liver disease (NAFLD) is associated with obesity and insulin resistance. It is also a predisposing factor for type 2 diabetes. Dietary factors are believed to contribute to all three diseases. NAFLD is characterized by increased intrahepatic fat and mitochondrial dysfunction, and its etiology may be attributed to excessive fructose intake. Consumption of high fructose corn syrup-55 (HFCS-55) stands at up to 15% of the average total daily energy intake in the United States, and...
59 CitationsSource
Cited By24
#1Yu Seol Lee (Yonsei University)H-Index: 3
#2Jeong Su Park (Yonsei University)H-Index: 7
Last. Soo Han Bae (Yonsei University)H-Index: 17
view all 5 authors...
#1Hye Jin Kim (NTU: Nanyang Technological University)H-Index: 2
#2Oliver Worsley (Genome Institute of Singapore)
Last. Sven PetterssonH-Index: 46
view all 14 authors...
Non-alcoholic fatty liver disease (NAFLD) is a metabolic liver disease that is thought to be reversible by changing the diet. To examine the impact of dietary changes on progression and cure of NAFLD, we fed mice a high-fat diet (HFD) or high-fructose diet (HFrD) for 9 weeks, followed by an additional 9 weeks, where mice were given normal chow diet. As predicted, the diet-induced NAFLD elicited changes in glucose tolerance, serum cholesterol, and triglyceride levels in both diet groups. Moreover...
#1Jung Bok Lee (Yonsei University)H-Index: 19
#2Jeong Su Park (Yonsei University)H-Index: 7
Last. Hak-Joon Sung (Yonsei University)H-Index: 21
view all 10 authors...
#1Masaya Shimada (Gidai: Gifu University)H-Index: 4
#2Yutaro Ichigo (Gidai: Gifu University)
Last. Takashi Hayakawa (Gidai: Gifu University)H-Index: 13
view all 7 authors...
Abstract Dietary supplementation with the major lipotrope myo-inositol (MI) potently reduces triglyceride (TG) content and expression levels of the fatty acid synthesis genes, for example, fatty acid synthase (FASN), in rat nonalcoholic fatty liver induced by high-fructose diet. Fatty acid synthesis genes are regulated by the carbohydrate-responsive element-binding protein (ChREBP) that exists in 2 isoforms: ChREBP-α and ChREBP-β. The gene encoding the latter isoform is more responsive to fructo...
#1Bo Li (Zhejiang University of Technology)H-Index: 1
#2Shan-Shan Lei (Zhejiang University of Technology)H-Index: 1
Last. Suhong Chen (WMU: Wenzhou Medical College)H-Index: 7
view all 13 authors...
Objectives. Fatty liver disease (FLD) is a major cause of morbidity and mortality worldwide. Dietary cholesterol and alcohol consumption are important risk factors for the progression of FLD, but whether and how alcohol induces more severe FLD with cholesterol ingestion remain unclear. Herein, we mainly used the Lieber-DeCarli diet to establish the FLD mouse model to investigate the synergistic effects of alcohol and cholesterol metabolism on liver damage. The indices of aspartate transaminase (...
1 CitationsSource
15 CitationsSource
#1Arunaksharan Narayanankutty (University of Calicut)H-Index: 7
#2Jeksy Jos Manalil (University of Calicut)H-Index: 4
Last. Achuthan C. Raghavamenon (University of Calicut)H-Index: 5
view all 9 authors...
Hepatosteatosis is a complex disorder, in which insulin resistance and associated dyslipidemic and inflammatory conditions are fundamental. Dietary habit, especially regular consumption of fat and sugar-rich diet, is an important risk factor. Coconut and mustard oils (CO and MO) are medium-chain saturated and monounsaturated fats that are common dietary ingredients among the Indian populations. Present study analyzed the effect of prolonged consumption of the fresh and thermally oxidized forms o...
6 CitationsSource
#1Jen Chieh Chuang (UTSW: University of Texas Southwestern Medical Center)H-Index: 17
#2Adam M. Lopez (UTSW: University of Texas Southwestern Medical Center)H-Index: 7
Last. Stephen D. TurleyH-Index: 29
view all 3 authors...
Abstract Esterified cholesterol (EC) and triglycerides, contained within lipoproteins taken up by cells, are hydrolysed by lysosomal acid lipase (LAL) in the late endosomal/lysosomal (E/L) compartment. The resulting unesterified cholesterol (UC) is transported via Niemann-Pick type C2 and C1 into the cytosolic compartment where it enters a putative pool of metabolically active cholesterol that is utilized in accordance with cellular needs. Loss-of-function mutations in LIPA, the gene encoding LA...
3 CitationsSource
#1Ángel BreaH-Index: 9
#2Xavier PintóH-Index: 41
Last. Juan Pedro-Botet (Autonomous University of Barcelona)H-Index: 30
view all 10 authors...
Resumen La enfermedad del higado graso no alcoholico (EHGNA) comprende una serie de lesiones hepaticas histologicamente similares a las inducidas por el alcohol en personas con un consumo del mismo muy escaso o nulo. La importancia de la EHGNA radica en su alta prevalencia en nuestras sociedades occidentales y, desde el punto de vista hepatico, en su progresiva evolucion desde esteatosis a esteatohepatitis, cirrosis y cancer de higado. Durante la ultima decada se ha observado que la EHGNA da lug...
7 CitationsSource
#1Ángel BreaH-Index: 9
#2Xavier PintóH-Index: 41
Last. Juan Pedro-Botet (Autonomous University of Barcelona)H-Index: 30
view all 10 authors...
Disease nonalcoholic fatty liver disease (NAFLD) comprises a series of histologically similar to those induced by alcohol consumption in people with very little or no liver damage same. The importance of NAFLD is its high prevalence in our Western societies, from the point of view liver in its progressive evolution from steatosis to steatohepatitis, cirrhosis and liver cancer. During the last decade it has been observed that NAFLD leads to an increased cardiovascular risk with accelerated athero...
1 CitationsSource